
Kiagene Biosciences Private Limited
About Kiagene Biosciences Private Limited
Data last updated:
Kiagene Biosciences Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 19 December 2023.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U21001DL2023PTC424028.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Balbir Kaur and Baldev Singh.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D – 5 Ramesh Nagar, New Delhi, Delhi, India – 110015.
Company details
Contact details
Kiagene Biosciences Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressD – 5 Ramesh Nagar, New Delhi, Delhi, India – 110015
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Kiagene Biosciences Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Kiagene Biosciences Private Limited, buy the company report.
Board of directors of Kiagene Biosciences Private Limited
Kiagene Biosciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Balbir Kaur | Director | 19 Dec 2023 | 2 Years 11 Months | Current |
| Baldev Singh | Director | 19 Dec 2023 | 2 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Kiagene Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kiagene Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Kiagene Biosciences Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Kiagene Biosciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Balbir Kaur was appointed as Director on 19 Dec 2023.
Frequently asked questions
Kiagene Biosciences is an active private limited company based in New Delhi, Delhi, India. The company works in paper and paper products, within the paper industry. It was incorporated on 19 December 2023 (3+ years old) and is registered under CIN U21001DL2023PTC424028.
Kiagene Biosciences has 2 current directors:
- Balbir Kaur - Director
- Baldev Singh - Director
The latest financial statements of Kiagene Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Kiagene Biosciences is U21001DL2023PTC424028. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kiagene Biosciences was incorporated on 19 December 2023, making it 3+ years old. It is registered with the Registrar of Companies, Delhi.
Balbir Kaur was appointed as Director on 19 Dec 2023. Baldev Singh was appointed as Director on 19 Dec 2023.
The registered office of Kiagene Biosciences is at D – 5 Ramesh Nagar, New Delhi, Delhi, India – 110015.
Kiagene Biosciences operates in the paper industry, in the paper and paper products segment.
Kiagene Biosciences can be reached at its registered office: D – 5 Ramesh Nagar, New Delhi, Delhi, India – 110015.
Kiagene Biosciences is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

